These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17875318)

  • 21. Significance of AF4-MLL reciprocal fusion in t(4;11) leukemias?
    Sanders DS; Muntean AG; Hess JL
    Leuk Res; 2011 Mar; 35(3):299-300. PubMed ID: 20952059
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins.
    Ng MH; Ng RK; Kong CT; Jin DY; Chan LC
    Exp Hematol; 2010 Jun; 38(6):481-8. PubMed ID: 20362031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele.
    Kowarz E; Burmeister T; Lo Nigro L; Jansen MW; Delabesse E; Klingebiel T; Dingermann T; Meyer C; Marschalek R
    Leukemia; 2007 Jun; 21(6):1232-8. PubMed ID: 17410185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4.
    Okuda H; Miyamoto R; Takahashi S; Kawamura T; Ichikawa J; Harada I; Tamura T; Yokoyama A
    Nat Commun; 2022 Nov; 13(1):6688. PubMed ID: 36335100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3K79 methylation profiles define murine and human MLL-AF4 leukemias.
    Krivtsov AV; Feng Z; Lemieux ME; Faber J; Vempati S; Sinha AU; Xia X; Jesneck J; Bracken AP; Silverman LB; Kutok JL; Kung AL; Armstrong SA
    Cancer Cell; 2008 Nov; 14(5):355-68. PubMed ID: 18977325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of an interphase fluorescence in situ hybridization approach for the detection of MLL gene rearrangements and of the MLL/AF9 fusion in acute myeloid leukemia.
    Cavazzini F; Bardi A; Tammiso E; Ciccone M; Russo-Rossi A; Divona D; Lo Coco F; Hernandez JM; Wlodarska I; Hagemeijer A; Castoldi G; Cuneo A
    Haematologica; 2006 Mar; 91(3):381-5. PubMed ID: 16503549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixed lineage leukemia: roles in human malignancies and potential therapy.
    Marschalek R
    FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the Activation Mechanism of Taspase1 which Controls the Oncogenic AF4-MLL Fusion Protein.
    Sabiani S; Geppert T; Engelbrecht C; Kowarz E; Schneider G; Marschalek R
    EBioMedicine; 2015 May; 2(5):386-95. PubMed ID: 26137584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.
    Drynan LF; Pannell R; Forster A; Chan NM; Cano F; Daser A; Rabbitts TH
    EMBO J; 2005 Sep; 24(17):3136-46. PubMed ID: 16096649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
    Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated KRAS Cooperates with MLL-AF4 to Promote Extramedullary Engraftment and Migration of Cord Blood CD34+ HSPC But Is Insufficient to Initiate Leukemia.
    Prieto C; Stam RW; Agraz-Doblas A; Ballerini P; Camos M; Castaño J; Marschalek R; Bursen A; Varela I; Bueno C; Menendez P
    Cancer Res; 2016 Apr; 76(8):2478-89. PubMed ID: 26837759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mll-AF4 Confers Enhanced Self-Renewal and Lymphoid Potential during a Restricted Window in Development.
    Barrett NA; Malouf C; Kapeni C; Bacon WA; Giotopoulos G; Jacobsen SEW; Huntly BJ; Ottersbach K
    Cell Rep; 2016 Jul; 16(4):1039-1054. PubMed ID: 27396339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-205 downregulates mixed-lineage-AF4 oncogene expression in acute lymphoblastic leukemia.
    Dou L; Li J; Zheng D; Li Y; Gao X; Xu C; Gao L; Wang L; Yu L
    Onco Targets Ther; 2013; 6():1153-60. PubMed ID: 24009426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells.
    Breese EH; Buechele C; Dawson C; Cleary ML; Porteus MH
    PLoS One; 2015; 10(9):e0136644. PubMed ID: 26351841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of Acute Leukemia Cells Including Cells with MLL-AF4 Rearrangements Induced by Jiyuan Oridonin A.
    Li X; Zhang F; Ke Y; Liu H; Hu Z; Wei L
    Recent Pat Anticancer Drug Discov; 2024 Jan; ():. PubMed ID: 38204268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key morphologic changes and DNA strand breaks in human lymphoid cells: discriminating apoptosis from necrosis.
    Fairbairn DW; Walburger DK; Fairbairn JJ; O'Neill KL
    Scanning; 1996 Sep; 18(6):407-16. PubMed ID: 8819349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of MLL-AFF1-positive acute lymphoblastic leukemia to tumor necrosis factor-alpha is mediated by S100A6 upregulation.
    Tamai H; Miyake K; Yamaguchi H; Takatori M; Dan K; Inokuchi K; Shimada T
    Blood Cancer J; 2011 Nov; 1(11):e38. PubMed ID: 22829076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.